Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
6.95
0.00 (0.00%)
At close: Sep 4, 2026, 4:00 PM EDT
7.05
+0.10 (1.44%)
Pre-market: Sep 8, 2026, 7:07 AM EDT
Ginkgo Bioworks Holdings Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Ginkgo Bioworks Holdings stock has a consensus rating of "Sell" and an average price target of $7.00. The average 1-year stock price forecast is 0.72% higher than the current stock price, while the lowest is $5.00 (-28.06%) and the highest is $9.00 (+29.50%).
Price Target: $7.00 (+0.72%)
Analyst Consensus: Sell
Price Target
ChartAnalyst Ratings
The average analyst rating for Ginkgo Bioworks Holdings stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 2 | 2 | 2 | 2 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 4 | 4 | 4 | 4 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Sell Reiterates $5 | Sell | Reiterates | $5 | -28.06% | Sep 4, 2026 |
| William Blair | William Blair | Sell Maintains n/a | Sell | Maintains | n/a | n/a | Aug 13, 2026 |
| TD Cowen | TD Cowen | Hold Downgrades $12 → $9 | Hold | Downgrades | $12 → $9 | +29.50% | Aug 7, 2026 |
Financial Forecast
Revenue This Year
85.03M
from 170.16M
Decreased by -50.03%
Revenue Next Year
96.40M
from 85.03M
Increased by 13.37%
EPS This Year
-3.20
from -3.66
EPS Next Year
-2.90
from -3.20
EPS and Forward PE are based on non-GAAP adjusted numbers.